Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.
1. A compound of the formula:
wherein:
X 1 is hydrogen, OR b , NR b R c , or SR b , wherein R b and R c are each independently:
hydrogen;
alkyl (C≦8) , aryl (C≦8) , aralkyl (C≦8) , acyl (C≦8) , or a substituted version of any of these groups; or
provided that R b is absent when the atom to which it is bound is part of a double bond, further provided that when R b is absent the atom to which it is bound is part of a double bond;
R 1 ′ is:
hydrogen, cyano, hydroxy, halo, or amino; or
alkyl (C≦8) , alkenyl (C≦8) , alkynyl (C≦8) , aryl (C≦8) , aralkyl (C≦8) , heteroaryl (C≦8) , heteroaralkyl (C≦8) , acyl (C≦8) , alkoxy (C≦8) , aryloxy (C≦8) , acyloxy (C≦8) , alkylamino (C≦8) , arylamino (C≦8) , amido (C≦8) , or a substituted version of any of these groups;
R 4 and R 5 are each independently alkyl (C≦8) or substituted alkyl (C≦8) ; and
R 6 and R 7 are each independently hydrogen or hydroxy;
or a salt or a tautomer thereof.
2. The compound of claim 1 , wherein X 1 is OR b and R b is absent.
3. The compound of claim 1 , wherein R 4 and R 5 are each independently alkyl (C≦4) .
4. The compound of claim 3 , wherein R 4 and R 5 are each methyl.
5. The compound of claim 1 , wherein R 6 and R 7 are each hydrogen.
6. The compound of claim 1 , further defined as:
7. A compound of the formula:
wherein:
R b is absent or hydrogen:
provided that R b is absent when the oxygen atom to which it is bound is part of a double bond, further provided that when R b is absent the oxygen atom to which it is bound is part of a double bond
provided that R b is hydrogen when the oxygen atom to which it is bound is not part of a double bond, further provided that when R b is hydrogen, the oxygen atom to which it is bound is not part of a double bond;
Y 1 is hydroxy, or —OC(O)H;
R 2 ′ is hydrogen or ═C(H)(OH);
R 3 is absent or hydrogen:
provided that R 3 is absent when the oxygen atom to which it is bound is part of a double bond, further provided that when R 3 is absent the oxygen atom to which it is bound is part of a double bond;
or a salt or a tautomer thereof.
8. A compound of the formula:
9. The compound of claim 7 , further defined as:
10. The compound of claim 7 , further defined as:
11. The compound of claim 7 , further defined as: